Molecular characterization of IgA1-receptor interactions implicated in IgA nephropathy.
Year: 2009
Type: article
Abstract: IgA nephropathy (IgAN) is the most common form of glomerulonephritis, an inflammatory disease of the kidney and a leading cause of end-stage renal disease.It is characterized by deposits of IgA1-containing immune complexes in the glomerular mesangium, which result in the infiltration of inflammatory immune cells, mesangial cell proliferation and mesangial matrix expansion.The fundamental cause of these complexes is underglycosylation of the IgA1 antibody.The two IgA receptors involved in the pathogenesis of IgAN are FcαRI and the transferrin receptor (TfR).FcαRI has been implicated in the initial phase of the disease-generation of circulating soluble IgA1-immune complexes-whereas TfR is involved in the latter phase, the trapping of IgA1-immune complexes in the glomerular mesangium.The studies described herein were focused on determining the effects of IgA1 glycosylation on the IgA1-FcαRI and IgA1-TfR interactions.In addition, we have used lectins specific for the aberrantly glycosylated IgA1 hinge to lay the groundwork for developing a non-invasive method for the diagnosis of the disease from blood samples of IgAN patients.Such an approach would be useful, given that IgAN is currently diagnosed by kidney biopsy.We carried out detailed biophysical studies on three IgA1 samples purified from human serum and recombinant IgA1-Fc and compared their binding to FcαRI.Our studies showed overlapping but distinct populations of -glycan species between IgA1 samples; however, these IgA1 samples bound FcαRI with similar affinities.Complete removal of the -glycan of IgA1 did not affect its binding to the receptor, suggesting that -glycosylation of IgA1 was not important for the IgA1-FcαRI interaction.We further characterized this interaction using different -glycosylation mutants of the receptor and found that receptor glycosylation has a minor effect.Taken together, these studies suggest that the -glycans of both IgA1 and the Role of the Transferrin receptor (TfR) in IgAN…………………………………………………25 Model for the pathogenesis of IgAN…………………………………………………………….26 Scope and thesis outline………………………………………………………………………….28 Chapter 2. Analysisof IgA1 -glycosylation and its contribution to Fcα α α αRI binding……………...29 Abstract…………………………………………………………………………………………..
Author: Michelle M. Gomes
Institution: University of Cincinnati
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2531618398
